The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition
Abstract
The increasing emergence of antimicrobial resistance in staphylococcal bacteria is a major health threat worldwide due to significant morbidity and mortality resulting from their associated hospital- or community-acquired infections. Dramatic decrease in the discovery of new antibiotics from the pharmaceutical industry coupled with increased use of sanitisers and disinfectants due to the ongoing COVID-19 pandemic can further aggravate the problem of antimicrobial resistance. Staphylococci utilise multiple mechanisms to circumvent the effects of antimicrobials. One of these resistance mechanisms is the export of antimicrobial agents through the activity of membrane-embedded multidrug efflux pump proteins. The use of efflux pump inhibitors in combination with currently approved antimicrobials is a promising strategy to potentiate their clinical efficacy against resistant strains of staphylococci, and simultaneously reduce the selection of resistant mutants. This review presents an overview of the current knowledge of staphylococcal efflux pumps, discusses their clinical impact, and summarises compounds found in the last decade from plant and synthetic origin that have the potential to be used as adjuvants to antibiotic therapy against multidrug resistant staphylococci. Critically, future high-resolution structures of staphylococcal efflux pumps could aid in design and development of safer, more target-specific and highly potent efflux pump inhibitors to progress into clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common efflux pump genes, tet(K) and tet(L), encode membrane-associated proteins that actively transport tetracycline out of the bacterial cell, reducing intracellular drug concentration and thereby limiting its efficacy [249,254,255].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [249]
In the citing paper
“Resistance to tetracyclines in S. aureus primarily occurs through active efflux pumps and ribosomal protection proteins.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [249]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243 · cited 1×
“In the presence of lethal stress, while the majority of bacterial cells perish, a subpopulation of bacterial cells known as persister cells can survive and resume growth after relief of the imposed lethal stress [4,5].”
BackgroundClinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“Thus, the activity of efflux pumps can contribute to the establishment of other resistance mechanisms [81,82].”
BackgroundAntibiotic resistance in Staphylococcus aureus. Current status and future prospects
Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 845
Jennings, M. C., Minbiole, K. P. C., & Wuest, W. M. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00047 · Cited by 651
Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150
PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
Clancy, C. J., Buehrle, D. J., & Nguyen, M. H. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa049 · Cited by 102
Research works printed but not linked: 296
- Reinl, 2016, UN declaration on antimicrobial resistance lacks targets, Lancet, 388, 1365, 10.1016/S0140-6736(16)31769-X · doi:10.1016/s0140-6736(16)31769-x
- Aslam, 2018, Antibiotic resistance: A rundown of a global crisis, Infect. Drug Resist., 11, 1645, 10.2147/IDR.S173867 · DOI · Paper page
- Coque, 2019, Defining and combating antibiotic resistance from One Health and Global Health perspectives, Nat. Microbiol., 4, 1432, 10.1038/s41564-019-0503-9 · DOI · Paper page
- Guo, 2020, Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus, Front. Cell. Infect. Microbiol., 10, 107, 10.3389/fcimb.2020.00107 · DOI · Paper page
- Loss, 2019, Staphylococcus aureus small colony variants (SCVs): News from a chronic prosthetic joint infection, Front. Cell. Infect. Microbiol., 9, 363, 10.3389/fcimb.2019.00363 · DOI
- Yan, 2019, Surviving as a community: Antibiotic tolerance and persistence in bacterial biofilms, Cell Host Microbe, 26, 15, 10.1016/j.chom.2019.06.002 · DOI · Paper page
- Skandalis, N., Maeusli, M., Papafotis, D., Miller, S., Lee, B., Theologidis, I., and Luna, B. (2021). Environmental Spread of Antibiotic Resistance. Antibiotics, 10. · DOI
- Trinh, 2018, One health relationships between human, animal, and environmental microbiomes: A mini-review, Front. Public Health, 6, 235, 10.3389/fpubh.2018.00235 · DOI · Paper page
- Collignon, P.J., and McEwen, S.A. (2019). One health—Its importance in helping to better control antimicrobial resistance. Trop. Med. Infect. Dis., 4. · DOI · Paper page
- Cay, 2014, Molecular diagnosis contributing for multi-drug resistant infection control, Curr. Treat. Options Infect. Dis., 6, 17, 10.1007/s40506-013-0006-9 · DOI
- 2017, Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms, Clin. Infect. Dis., 65, 644, 10.1093/cid/cix411 · DOI · Paper page
- Knight, 2021, Antimicrobial resistance and COVID-19: Intersections and implications, eLife, 10, e64139, 10.7554/eLife.64139 · DOI · Paper page
- Kampf, 2018, Challenging biocide tolerance with antiseptic stewardship, J. Hosp. Infect., 100, e37, 10.1016/j.jhin.2018.07.014 · doi:10.1016/j.jhin.2018.07.014
- Paul, 2019, Biocides and health-care agents are more than just antibiotics: Inducing cross to co-resistance in microbes, Ecotoxicol. Environ. Saf., 174, 601, 10.1016/j.ecoenv.2019.02.083 · DOI
- Blanco, P., Hernando-Amado, S., Reales-Calderon, J.A., Corona, F., Lira, F., Alcalde-Rico, M., Bernardini, A., Sanchez, M.B., and Martinez, J.L. (2016). Bacterial multidrug efflux pumps: Much more than antibiotic resistance determinants. Microorganisms, 4. · DOI · Paper page
- Hoffman, P.S. (2020). Antibacterial discovery: 21st century challenges. Antibiotics, 9. · DOI
- Venter, 2019, Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens, Biosci. Rep., 39, BSR20180474, 10.1042/BSR20180474 · DOI
- Leitão, J.H. (2020). New insights into antibacterial compounds: From synthesis and discovery to molecular mechanisms of action. Antibiotics, 9. · doi:10.3390/antibiotics9080471
- Yu, 2020, Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies, Expert Opin. Drug Deliv., 17, 1151, 10.1080/17425247.2020.1779697 · DOI
- Tyers, 2019, Drug combinations: A strategy to extend the life of antibiotics in the 21st century, Nat. Rev. Microbiol., 17, 141, 10.1038/s41579-018-0141-x · DOI · Paper page
- Wright, 2016, Antibiotic adjuvants: Rescuing antibiotics from resistance, Trends Microbiol., 24, 862, 10.1016/j.tim.2016.06.009 · DOI · Paper page
- Hancock, 2012, Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance, Clin. Microbiol. Rev., 25, 661, 10.1128/CMR.00043-12 · DOI · Paper page
- Costa, 2013, Multidrug efflux pumps in Staphylococcus aureus: An update, Open Microbiol. J., 7, 59, 10.2174/1874285801307010059 · DOI · Paper page
- 2016, Synergism between antibiotics and plant extracts or essential oils with efflux pump inhibitory activity in coping with multidrug-resistant staphylococci, Phytochem. Rev., 15, 651, 10.1007/s11101-016-9458-0 · DOI
- Otto, 2009, Staphylococcus epidermidis—The ‘accidental’ pathogen, Nat. Rev. Microbiol., 7, 555, 10.1038/nrmicro2182 · DOI · Paper page
- França, A., Gaio, V., Lopes, N., and Melo, L.D. (2021). Virulence factors in coagulase-negative Staphylococci. Pathogens, 10. · DOI
- Le, 2015, Quorum-sensing regulation in staphylococci—An overview, Front. Microbiol., 6, 1174, 10.3389/fmicb.2015.01174 · DOI · Paper page
- Heilmann, 2019, Are coagulase-negative staphylococci virulent?, Clin. Microbiol. Infect., 25, 1071, 10.1016/j.cmi.2018.11.012 · DOI · Paper page
- Monsen, 2012, Coagulase-negative staphylococci: Update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus, Eur. J. Clin. Microbiol. Infect. Dis., 31, 7, 10.1007/s10096-011-1270-6 · DOI · Paper page
- Yong, 2019, Biofilm formation by staphylococci in health-related environments and recent reports on their control using natural compounds, Crit. Rev. Microbiol., 45, 201, 10.1080/1040841X.2019.1573802 · DOI
- Le, 2017, Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period, Epidemiol. Infect., 145, 2631, 10.1017/S0950268817001571 · DOI
- Banerjee, 2021, Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus, Sci. Rep., 11, 1, 10.1038/s41598-021-88099-6 · DOI
- Jiang, 2019, Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation, Proc. Natl. Acad. Sci. USA, 116, 3722, 10.1073/pnas.1812066116 · DOI
- MacIntyre, 2017, Pandemics, public health emergencies and antimicrobial resistance-putting the threat in an epidemiologic and risk analysis context, Arch. Public Health, 75, 1, 10.1186/s13690-017-0223-7 · DOI
- Miragaia, 2018, Factors contributing to the evolution of mecA-mediated beta-lactam resistance in Staphylococci: Update and new insights from whole genome sequencing (WGS), Front. Microbiol., 9, 2723, 10.3389/fmicb.2018.02723 · DOI · Paper page
- Fishovitz, 2014, Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, IUBMB Life, 66, 572, 10.1002/iub.1289 · DOI · Paper page
- Venter, 2017, Antimicrobial resistance in healthcare, agriculture and the environment: The biochemistry behind the headlines, Essays Biochem., 61, 1, 10.1042/EBC20160053 · DOI
- Wernli, 2017, Mapping global policy discourse on antimicrobial resistance, BMJ Glob. Health, 2, e000378, 10.1136/bmjgh-2017-000378 · DOI
- Sirijatuphat, R., Sripanidkulchai, K., Boonyasiri, A., Rattanaumpawan, P., Supapueng, O., Kiratisin, P., and Thamlikitkul, V. (2018). Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia. PLoS ONE, 13. · DOI
- Li, 2018, Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections, J. Orthop. Res., 36, 22, 10.1002/jor.23656 · DOI · Paper page
- Senn, 2016, The stealthy superbug: The role of asymptomatic enteric carriage in maintaining a long-term hospital outbreak of ST228 methicillin-resistant Staphylococcus aureus, MBio, 7, e02039-15, 10.1128/mBio.02039-15 · DOI
- Lee, 2017, Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization, J. Antimicrob. Chemother., 72, 2461, 10.1093/jac/dkx200 · DOI
- Hassoun, 2017, Incidence, prevalence, and management of MRSA bacteremia across patient populations—A review of recent developments in MRSA management and treatment, Crit. Care, 21, 211, 10.1186/s13054-017-1801-3 · DOI · Paper page
- Agostino, 2017, The increasing importance of community-acquired methicillin-resistant Staphylococcus aureus infections, Med. J. Aust., 207, 388, 10.5694/mja17.00089 · DOI
- Choo, 2017, Community-associated methicillin-resistant Staphylococcus aureus in nosocomial infections, Infect. Chemother., 49, 158, 10.3947/ic.2017.49.2.158 · DOI
- Kong, E.F., Johnson, J.K., and Jabra-Rizk, M.A. (2016). Community-associated methicillin-resistant Staphylococcus aureus: An enemy amidst us. PLoS Pathog., 12. · DOI
- Uehara, Y., Sasaki, T., Baba, T., Lu, Y., Imajo, E., Sato, Y., Tanno, S., Furuichi, M., Kawada, M., and Hiramatsu, K. (2019). Regional outbreak of community-associated methicillin-resistant Staphylococcus aureus ST834 in Japanese children. BMC Infect. Dis., 19. · DOI
- McDougal, 2010, Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States, Antimicrob. Agents Chemother., 54, 3804, 10.1128/AAC.00351-10 · DOI · Paper page
- Garoy, 2019, Methicillin-resistant Staphylococcus aureus (MRSA): Prevalence and antimicrobial sensitivity pattern among patients—A multicenter study in Asmara, Eritrea, Can. J. Infect. Dis. Med. Microbiol., 2019, 8321834, 10.1155/2019/8321834 · DOI · Paper page
- Choo, 2016, Treatment of methicillin-resistant Staphylococcus aureus bacteremia, Infect. Chemother., 48, 267, 10.3947/ic.2016.48.4.267 · DOI · Paper page
- Sarkar, 2017, A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics, MedChemComm, 8, 516, 10.1039/C6MD00585C · DOI · Paper page
- McGuinness, 2017, Vancomycin resistance in Staphylococcus aureus, Yale J. Biol. Med., 90, 269
- Wang, 2018, Insights into key interactions between vancomycin and bacterial cell wall structures, ACS Omega, 3, 37, 10.1021/acsomega.7b01483 · DOI
- Pantosti, 2007, Mechanisms of antibiotic resistance in Staphylococcus aureus, Future Microbiol., 2, 323, 10.2217/17460913.2.3.323 · DOI · Paper page
- Touati, 2021, Fitness cost of antibiotic resistance in Staphylococcus aureus: A systematic review, Microb. Drug Resist., 9, 1218, 10.1089/mdr.2020.0426 · DOI
- Malachowa, 2010, Mobile genetic elements of Staphylococcus aureus, Cell. Mol. Life Sci., 67, 3057, 10.1007/s00018-010-0389-4 · DOI · Paper page
- Haaber, 2017, Transfer of antibiotic resistance in Staphylococcus aureus, Trends Microbiol., 25, 893, 10.1016/j.tim.2017.05.011 · DOI · Paper page
- Bukowski, 2019, Prevalence of antibiotic and heavy metal resistance determinants and virulence-related genetic elements in plasmids of Staphylococcus aureus, Front. Microbiol., 10, 805, 10.3389/fmicb.2019.00805 · DOI
- Sargison, 2020, Advances in transposon mutagenesis of Staphylococcus aureus: Insights into pathogenesis and antimicrobial resistance, Trends Microbiol., 29, 282, 10.1016/j.tim.2020.11.003 · doi:10.1016/j.tim.2020.11.003
- Jamrozy, D., Coll, F., Mather, A.E., Harris, S.R., Harrison, E.M., MacGowan, A., Karas, A., Elston, T., Estee Torok, M., and Parkhill, J. (2017). Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: Temporal changes correlated with frequent loss and gain events. BMC Genomics, 18. · DOI
- Lewis, 2020, The science of antibiotic discovery, Cell, 181, 29, 10.1016/j.cell.2020.02.056 · DOI · Paper page
- Earls, M.R., Kinnevey, P.M., Brennan, G.I., Lazaris, A., Skally, M., O’Connell, B., Humphreys, H., Shore, A.C., and Coleman, D.C. (2017). The recent emergence in hospitals of multidrug-resistant community-associated sequence type 1 and spa type t127 methicillin-resistant Staphylococcus aureus investigated by whole-genome sequencing: Implications for screening. PLoS ONE, 12. · DOI
- Weigel, 2003, Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus, Science, 302, 1569, 10.1126/science.1090956 · DOI · Paper page
- Qureshi, N.K., Yin, S., and Boyle-Vavra, S. (2014). The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus. PLoS ONE, 9. · DOI
- Xia, 2016, Nosocomial infection and its molecular mechanisms of antibiotic resistance, Biosci. Trends, 10, 14, 10.5582/bst.2016.01020 · DOI
- Nawrocki, 2014, Antimicrobial peptide resistance mechanisms of Gram-positive bacteria, Antibiotics, 3, 461, 10.3390/antibiotics3040461 · DOI
- Peacock, 2015, Mechanisms of methicillin resistance in Staphylococcus aureus, Annu. Rev. Biochem., 84, 577, 10.1146/annurev-biochem-060614-034516 · DOI · Paper page
- Tanaka, 2013, Structural basis for the drug extrusion mechanism by a MATE multidrug transporter, Nature, 496, 247, 10.1038/nature12014 · DOI · Paper page
- Hughes, 2015, Evolutionary consequences of drug resistance: Shared principles across diverse targets and organisms, Nat. Rev. Genet., 16, 459, 10.1038/nrg3922 · DOI · Paper page
- Melander, 2017, The challenge of overcoming antibiotic resistance: An adjuvant approach?, ACS Infect. Dis., 3, 559, 10.1021/acsinfecdis.7b00071 · DOI · Paper page
- Lamut, 2019, Efflux pump inhibitors of clinically relevant multidrug resistant bacteria, Med. Res. Rev., 39, 2460, 10.1002/med.21591 · DOI · Paper page
- Pu, 2016, Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells, Mol. Cell, 62, 284, 10.1016/j.molcel.2016.03.035 · DOI · Paper page
- Pu, 2017, Active efflux in dormant bacterial cells—New insights into antibiotic persistence, Drug Resist. Updates, 30, 7, 10.1016/j.drup.2016.11.002 · DOI
- Ebbensgaard, A.E., Løbner-Olesen, A., and Frimodt-Møller, J. (2020). The role of efflux pumps in the transition from low-level to clinical sntibiotic resistance. Antibiotics, 9. · DOI
- Henderson, 2021, Physiological Functions of Bacterial “Multidrug” Efflux Pumps, Chem. Rev., 121, 5417, 10.1021/acs.chemrev.0c01226 · DOI · Paper page
- Poole, 2002, Mechanisms of bacterial biocide and antibiotic resistance, J. Appl. Microbiol., 92, 55s, 10.1046/j.1365-2672.92.5s1.8.x · DOI · Paper page
- Ramaswamy, 2017, Molecular rationale behind the differential substrate specificity of bacterial RND multi-drug transporters, Sci. Rep., 7, 8075, 10.1038/s41598-017-08747-8 · DOI
- Piddock, 2006, Multidrug-resistance efflux pumps—Not just for resistance, Nat. Rev. Microbiol., 4, 629, 10.1038/nrmicro1464 · DOI · Paper page
- Hassan, 2019, Short-chain diamines are the physiological substrates of PACE family efflux pumps, Proc. Natl. Acad. Sci. USA, 116, 18015, 10.1073/pnas.1901591116 · doi:10.1073/pnas.1901591116
- Short, 2021, Spermidine and spermine are the natural substrates of the Acinetobacter baumannii AmvA multidrug efflux pump, Commun. Biol., 4, 1114, 10.1038/s42003-021-02629-6 · DOI
- Du, 2018, Multidrug efflux pumps: Structure, function and regulation, Nat. Rev. Microbiol., 16, 523, 10.1038/s41579-018-0048-6 · DOI · Paper page
- Alav, 2018, Role of bacterial efflux pumps in biofilm formation, J. Antimicrob. Chemother., 73, 2003, 10.1093/jac/dky042 · DOI · Paper page
- Schilcher, 2020, Staphylococcal biofilm development: Structure, regulation, and treatment strategies, Microbiol. Mol. Biol. Rev., 84, e00026-19, 10.1128/MMBR.00026-19 · DOI · Paper page
- Grkovic, 2002, Regulation of bacterial drug export systems, Microbiol. Mol. Biol. Rev., 66, 671, 10.1128/MMBR.66.4.671-701.2002 · DOI · Paper page
- Paulsen, 1996, Proton-dependent multidrug efflux systems, Microbiol. Rev., 60, 575, 10.1128/mr.60.4.575-608.1996 · doi:10.1128/mr.60.4.575-608.1996 · Paper page
- Sun, 2014, Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations, Biochem. Biophys. Res. Commun., 453, 254, 10.1016/j.bbrc.2014.05.090 · DOI · Paper page
- Webber, 2003, The importance of efflux pumps in bacterial antibiotic resistance, J. Antimicrob. Chemother., 51, 9, 10.1093/jac/dkg050 · DOI · Paper page
- Poole, 2004, Efflux-mediated multiresistance in Gram-negative bacteria, Clin. Microbiol. Infect., 10, 12, 10.1111/j.1469-0691.2004.00763.x · DOI · Paper page
- Blair, 2016, How to measure export via bacterial multidrug resistance efflux pumps, mBio, 7, e00840-16, 10.1128/mBio.00840-16 · doi:10.1128/mbio.00840-16
- Martins, 2013, A simple method for assessment of MDR bacteria for over-expressed efflux pumps, Open Microbiol. J., 7, 72, 10.2174/1874285801307010072 · DOI
- Whittle, 2019, Flow cytometric analysis of efflux by dye accumulation, Front. Microbiol., 10, 2319, 10.3389/fmicb.2019.02319 · DOI
- Chitsaz, 2017, The role played by drug efflux pumps in bacterial multidrug resistance, Essays Biochem., 61, 127, 10.1042/EBC20160064 · DOI
- Kumar, 2005, Bacterial resistance to antibiotics: Active efflux and reduced uptake, Adv. Drug Deliv. Rev., 57, 1486, 10.1016/j.addr.2005.04.004 · DOI · Paper page
- Alnaseri, 2015, Inducible expression of a resistance-nodulation-division-type efflux pump in Staphylococcus aureus provides resistance to linoleic and arachidonic acids, J. Bacteriol., 197, 1893, 10.1128/JB.02607-14 · DOI
- Lekshmi, 2018, Modulation of antimicrobial efflux pumps of the major facilitator superfamily in Staphylococcus aureus, AIMS Microbiol., 4, 1, 10.3934/microbiol.2018.1.1 · DOI
- Littlejohn, 1991, Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus, Gene, 101, 59, 10.1016/0378-1119(91)90224-Y · DOI
- Sasatsu, 1989, Nucleotide sequence of a gene that encodes resistance to ethidium bromide from a transferable plasmid in Staphylococcus aureus, Nucleic Acids Res., 17, 10103, 10.1093/nar/17.23.10103 · DOI
- Paulsen, 1995, Molecular characterization of the staphylococcal multidrug resistance export protein QacC, J. Bacteriol., 177, 2827, 10.1128/jb.177.10.2827-2833.1995 · DOI
- Poget, 2010, 1H, 13C, 15N backbone NMR assignments of the Staphylococcus aureus small multidrug-resistance pump (Smr) in a functionally active conformation, Biomol. NMR Assign., 4, 139, 10.1007/s12104-010-9228-7 · doi:10.1007/s12104-010-9228-7
- Putman, 2000, Molecular properties of bacterial multidrug transporters, Microbiol. Mol. Biol. Rev., 64, 672, 10.1128/MMBR.64.4.672-693.2000 · DOI · Paper page
- Li, X.Z., Elkins, C.A., and Zgurskaya, H.I. (2016). Small multidrug resistance efflux pumps. Efflux-Mediated Antimicrobial Resistance in Bacteria, Springer. · doi:10.1007/978-3-319-39658-3
- Grinius, 1994, Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump, J. Biol. Chem., 269, 29998, 10.1016/S0021-9258(18)43980-4 · DOI
- Bay, 2008, Small multidrug resistance proteins: A multidrug transporter family that continues to grow, Biochim. Biophys. Acta, 1778, 1814, 10.1016/j.bbamem.2007.08.015 · DOI · Paper page
- LaBreck, 2020, Systematic analysis of efflux pump-mediated antiseptic resistance in Staphylococcus aureus suggests a need for greater antiseptic stewardship, mSphere, 5, e00959-19, 10.1128/mSphere.00959-19 · DOI
- Leelaporn, 1995, Multidrug resistance plasmid pSK108 from coagulase-negative staphylococci; Relationships to Staphylococcus aureus qacC plasmids, Plasmid, 34, 62, 10.1006/plas.1995.1034 · doi:10.1006/plas.1995.1034
- Wassenaar, 2016, The qacC gene has recently spread between rolling circle plasmids of Staphylococcus, indicative of a novel gene transfer mechanism, Front. Microbiol., 7, 1528, 10.3389/fmicb.2016.01528 · DOI
- Wassenaar, 2015, Review and phylogenetic analysis of qac genes that reduce susceptibility to quaternary ammonium compounds in Staphylococcus species, Eur. J. Microbiol. Immunol., 5, 44, 10.1556/EuJMI-D-14-00038 · DOI · Paper page
- Littlejohn, 1992, Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus, FEMS Microbiol. Lett., 74, 259, 10.1111/j.1574-6968.1992.tb05376.x · DOI
- Horner, 2012, Reduced susceptibility to chlorhexidine in Staphylococci: Is it increasing and does it matter?, J. Antimicrob. Chemother., 67, 2547, 10.1093/jac/dks284 · DOI · Paper page
- Baines, 2019, Remodeling of pSK1 family plasmids and enhanced chlorhexidine tolerance in a dominant hospital lineage of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 63, e02356-18, 10.1128/AAC.02356-18 · DOI
- Leelaporn, 1994, Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci, J. Med. Microbiol., 40, 214, 10.1099/00222615-40-3-214 · DOI · Paper page
- Smith, 2008, The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates, J. Antimicrob. Chemother., 61, 78, 10.1093/jac/dkm395 · DOI · Paper page
- Villet, 2014, Regulation of expression of abcA and its response to environmental conditions, J. Bacteriol., 196, 1532, 10.1128/JB.01406-13 · DOI
- Leclercq, 2011, Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates, Int. J. Antimicrob. Agents, 37, 118, 10.1016/j.ijantimicag.2010.10.008 · DOI
- Wang, 2019, Baicalin inhibits biofilm formation and the quorum-sensing system by regulating the MsrA drug efflux pump in Staphylococcus saprophyticus, Front. Microbiol., 10, 2800, 10.3389/fmicb.2019.02800 · DOI
- Dawson, 2007, Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP, FEBS Lett., 581, 935, 10.1016/j.febslet.2007.01.073 · DOI · Paper page
- Velamakanni, 2008, Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus, Biochemistry, 47, 9300, 10.1021/bi8006737 · doi:10.1021/bi8006737
- Allignet, 1992, Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginiamycin A-like antibiotics, Gene, 117, 45, 10.1016/0378-1119(92)90488-B · DOI
- Vimberg, 2020, Ribosome-mediated attenuation of vga (A) expression is shaped by the antibiotic resistance specificity of Vga (A) protein variants, Antimicrob. Agents Chemother., 64, e00666-20, 10.1128/AAC.00666-20 · DOI
- Allignet, 1997, Characterization of a new staphylococcal gene, vgaB, encoding a putative ABC transporter conferring resistance to streptogramin A and related compounds, Gene, 202, 133, 10.1016/S0378-1119(97)00464-2 · DOI
- Chesneau, 2005, Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci, Antimicrob. Agents Chemother., 49, 973, 10.1128/AAC.49.3.973-980.2005 · DOI
- Kaatz, 2005, Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein, Antimicrob. Agents Chemother., 49, 1857, 10.1128/AAC.49.5.1857-1864.2005 · DOI · Paper page
- McAleese, 2005, A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline, Antimicrob. Agents Chemother., 49, 1865, 10.1128/AAC.49.5.1865-1871.2005 · DOI · Paper page
- Tintino, 2021, Chemical synthesis, molecular docking and MepA efflux pump inhibitory effect by 1, 8-naphthyridines sulfonamides, Eur. J. Pharm. Sci., 160, 105753, 10.1016/j.ejps.2021.105753 · DOI
- Kehrenberg, 2005, Florfenicol-chloramphenicol exporter gene fexA is part of the novel transposon Tn558, Antimicrob. Agents Chemother., 49, 813, 10.1128/AAC.49.2.813-815.2005 · DOI
- Floyd, 2010, LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus, Antimicrob. Agents Chemother., 54, 5406, 10.1128/AAC.00580-10 · DOI · Paper page
- Nava, 2020, Evidence of calcium signaling and modulation of the LmrS multidrug resistant efflux pump activity by Ca2+ ions in S. aureus, Front. Microbiol., 11, 573388, 10.3389/fmicb.2020.573388 · DOI
- Huang, 2004, Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus, Antimicrob. Agents Chemother., 48, 909, 10.1128/AAC.48.3.909-917.2004 · DOI
- Yamada, 2006, Functional gene cloning and characterization of MdeA, a multidrug efflux pump from Staphylococcus aureus, Biol. Pharm. Bull., 29, 801, 10.1248/bpb.29.801 · doi:10.1248/bpb.29.801
- Yu, 2002, NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes, J. Bacteriol., 184, 1370, 10.1128/JB.184.5.1370-1377.2002 · DOI
- Costa, 2019, Genetic diversity of norA, coding for a main efflux pump of Staphylococcus aureus, Front. Genet., 9, 710, 10.3389/fgene.2018.00710 · DOI
- Hooper, 2010, Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus, J. Bacteriol., 192, 2525, 10.1128/JB.00018-10 · DOI
- Rajabi, 2020, Evaluation of multidrug efflux pump expression in clinical isolates of Staphylococcus aureus, Gene Rep., 18, 100537, 10.1016/j.genrep.2019.100537 · DOI
- Strahilevitz, 2006, NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 1104, 10.1128/AAC.50.3.1104-1107.2006 · DOI
- Kumar, 2020, Isolation and structural characterization of a Zn2+-bound single-domain antibody against NorC, a putative multidrug efflux transporter in bacteria, J. Biol. Chem., 295, 55, 10.1074/jbc.RA119.010902 · DOI
- Paulsen, 1996, Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity, Proc. Natl. Acad. Sci. USA, 93, 3630, 10.1073/pnas.93.8.3630 · DOI · Paper page
- Mitchell, 1998, QacA multidrug efflux pump from Staphylococcus aureus: Comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones, Antimicrob. Agents Chemother., 42, 475, 10.1128/AAC.42.2.475 · DOI
- Majumder, 2019, Dissection of protonation sites for antibacterial recognition and transport in QacA, a multi-drug efflux transporter, J. Mol. Biol., 431, 2163, 10.1016/j.jmb.2019.03.015 · DOI
- Hassanzadeh, 2020, Epidemiology of efflux pumps genes mediating resistance among Staphylococcus aureus; A systematic review, Microb. Pathog., 139, 103850, 10.1016/j.micpath.2019.103850 · DOI
- Yamada, 2006, Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus, Biol. Pharm. Bull., 29, 554, 10.1248/bpb.29.554 · DOI
- Ginn, 2000, The TetA (K) tetracycline/H+ antiporter from Staphylococcus aureus: Mutagenesis and functional analysis of motif C, J. Bacteriol., 182, 1492, 10.1128/JB.182.6.1492-1498.2000 · DOI
- Wang, 2018, Tet38 efflux pump contributes to fosfomycin resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 62, e00927-18, 10.1128/AAC.00927-18 · doi:10.1128/aac.00927-18
- Nguyen, 2019, Inactivation of farR causes high rhodomyrtone resistance and increased pathogenicity in Staphylococcus aureus, Front. Microbiol., 10, 1157, 10.3389/fmicb.2019.01157 · DOI
- Scherf, 2020, Effect of terpinolene against the resistant Staphylococcus aureus strain, carrier of the efflux pump QacC and β-lactamase gene, and its toxicity in the Drosophila melanogaster model, Microb. Pathog., 149, 104528, 10.1016/j.micpath.2020.104528 · doi:10.1016/j.micpath.2020.104528
- Bjorland, 2003, Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius, Antimicrob. Agents Chemother., 47, 3046, 10.1128/AAC.47.10.3046-3052.2003 · DOI
- Heir, 1999, The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry, J. Appl. Microbiol., 86, 378, 10.1046/j.1365-2672.1999.00672.x · DOI
- Heir, 1998, The Staphylococcus qacH gene product: A new member of the SMR family encoding multidrug resistance, FEMS Microbiol. Lett., 163, 49, 10.1111/j.1574-6968.1998.tb13025.x · DOI
- Narui, 2002, Cloning and characterization of a novel chromosomal drug efflux gene in Staphylococcus aureus, Biol. Pharm. Bull., 25, 1533, 10.1248/bpb.25.1533 · DOI
- Schindler, 2016, Multidrug efflux pumps of Gram-positive bacteria, Drug Resist. Updates, 27, 1, 10.1016/j.drup.2016.04.003 · DOI · Paper page
- Omote, 2006, The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations, Trends Pharmacol. Sci., 27, 587, 10.1016/j.tips.2006.09.001 · DOI · Paper page
- Kaatz, 2006, MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein, Antimicrob. Agents Chemother., 50, 1276, 10.1128/AAC.50.4.1276-1281.2006 · DOI
- Schindler, 2013, Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump, J. Bacteriol., 195, 523, 10.1128/JB.01679-12 · doi:10.1128/jb.01679-12
- Huet, 2008, Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes, Microbiology, 154, 3144, 10.1099/mic.0.2008/021188-0 · DOI
- Fang, 2020, Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus, J. Glob. Antimicrob. Resist., 22, 631, 10.1016/j.jgar.2020.06.005 · doi:10.1016/j.jgar.2020.06.005
- Birukou, 2014, Structural mechanism of transcription regulation of the Staphylococcus aureus multidrug efflux operon mepRA by the MarR family repressor MepR, Nucleic Acids Res., 42, 2774, 10.1093/nar/gkt1215 · doi:10.1093/nar/gkt1215
- Rees, 2009, ABC transporters: The power to change, Nat. Rev. Mol. Cell Biol., 10, 218, 10.1038/nrm2646 · DOI · Paper page
- 2001, The AbcA transporter of Staphylococcus aureus affects cell autolysis, Antimicrob. Agents Chemother., 45, 407, 10.1128/AAC.45.2.407-412.2001 · DOI
- Dawson, 2006, Structure of a bacterial multidrug ABC transporter, Nature, 443, 180, 10.1038/nature05155 · DOI · Paper page
- Stockner, 2009, Data-driven homology modelling of P-glycoprotein in the ATP-bound state indicates flexibility of the transmembrane domains, FEBS J., 276, 964, 10.1111/j.1742-4658.2008.06832.x · DOI
- Reynolds, 2003, Msr(A) and related macrolide/streptogramin resistance determinants: Incomplete transporters?, Int. J. Antimicrob. Agents, 22, 228, 10.1016/S0924-8579(03)00218-8 · DOI
- Quistgaard, 2016, Understanding transport by the major facilitator superfamily (MFS): Structures pave the way, Nat. Rev. Mol. Cell Biol., 17, 123, 10.1038/nrm.2015.25 · DOI · Paper page
- Saier, 2014, The transporter classification database, Nucleic Acids Res., 42, D251, 10.1093/nar/gkt1097 · DOI · Paper page
- Reddy, 2012, The major facilitator superfamily (MFS) revisited, FEBS J., 279, 2022, 10.1111/j.1742-4658.2012.08588.x · DOI · Paper page
- Jin, 2001, Twelve-transmembrane-segment (TMS) version (DeltaTMS VII-VIII) of the 14-TMS Tet(L) antibiotic resistance protein retains monovalent cation transport modes but lacks tetracycline efflux capacity, J. Bacteriol., 183, 2667, 10.1128/JB.183.8.2667-2671.2001 · DOI
- Tanabe, 2009, The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro, Biochem. Biophys. Res. Commun., 380, 338, 10.1016/j.bbrc.2009.01.081 · DOI
- Li, 2004, Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis, Antimicrob. Agents Chemother., 48, 2415, 10.1128/AAC.48.7.2415-2423.2004 · DOI · Paper page
- Saier, 2003, Tracing pathways of transport protein evolution, Mol. Microbiol., 48, 1145, 10.1046/j.1365-2958.2003.03499.x · DOI
- Hassan, 2007, Active export proteins mediating drug resistance in staphylococci, J. Mol. Microbiol. Biotechnol., 12, 180
- Ganesan, 2016, Identification of benzochromene derivatives as a highly specific NorA efflux pump inhibitor to mitigate the drug resistant strains of S. aureus, RSC Adv., 6, 30258, 10.1039/C6RA01981A · DOI
- Yoshida, 1990, Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones, J. Bacteriol., 172, 6942, 10.1128/jb.172.12.6942-6949.1990 · DOI · Paper page
- Palazzotti, D., Bissaro, M., Bolcato, G., Astolfi, A., Felicetti, T., Sabatini, S., Sturlese, M., Cecchetti, V., Barreca, M.L., and Moro, S. (2019). Deciphering the molecular recognition mechanism of multidrug resistance Staphylococcus aureus NorA efflux pump using a supervised molecular dynamics approach. Int. J. Mol. Sci., 20. · doi:10.3390/ijms20164041
- Neyfakh, 1993, Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter, Antimicrob. Agents Chemother., 37, 128, 10.1128/AAC.37.1.128 · DOI · Paper page
- Buonerba, 2017, Improved potency of indole-based NorA efflux pump inhibitors: From serendipity toward rational design and development, J. Med. Chem., 60, 517, 10.1021/acs.jmedchem.6b01281 · DOI
- Zimmermann, 2017, Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus, J. Microbiol. Methods, 142, 39, 10.1016/j.mimet.2017.09.001 · doi:10.1016/j.mimet.2017.09.001
- Handzlik, 2013, Recent advances in multi-drug resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus, Antibiotics, 2, 28, 10.3390/antibiotics2010028 · DOI · Paper page
- Espinoza, 2019, Essential oil, extracts, and sesquiterpenes obtained from the heartwood of pilgerodendron uviferum act as potential inhibitors of the Staphylococcus aureus NorA multidrug efflux pump, Front. Microbiol., 10, 337, 10.3389/fmicb.2019.00337 · DOI
- AlMatar, 2021, Efflux pump inhibitors: New updates, Pharmacol. Rep., 73, 1, 10.1007/s43440-020-00160-9 · DOI
- Bhaskar, 2016, Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus, Drug Des. Devel. Ther., 10, 3237, 10.2147/DDDT.S113556 · DOI
- Thakur, 2021, A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance, Eur. J. Pharmacol., 903, 174151, 10.1016/j.ejphar.2021.174151 · DOI
- Costa, 2016, Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins, J. Appl. Microbiol., 121, 1312, 10.1111/jam.13258 · DOI
- Felicetti, 2017, Searching for novel inhibitors of the S. aureus NorA efflux pump: Synthesis and biological evaluation of the 3-Phenyl-1,4-benzothiazine Analogues, ChemMedChem, 12, 1293, 10.1002/cmdc.201700286 · DOI
- Singh, 2017, Boeravinone B, a novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria, Front. Microbiol., 8, 1868, 10.3389/fmicb.2017.01868 · DOI
- Ding, 2008, NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses, J. Bacteriol., 190, 7123, 10.1128/JB.00655-08 · DOI · Paper page
- Dunman, 2005, MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus, J. Bacteriol., 187, 2395, 10.1128/JB.187.7.2395-2405.2005 · DOI · Paper page
- Hooper, 2015, Mechanisms of drug resistance: Quinolone resistance, Ann. N. Y. Acad. Sci., 1354, 12, 10.1111/nyas.12830 · DOI · Paper page
- Hsing, 2012, Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA, J. Bacteriol., 194, 1823, 10.1128/JB.06503-11 · DOI
- Briaud, 2019, Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells, Sci. Rep., 9, 1, 10.1038/s41598-019-52975-z · DOI
- Villet, 2014, Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin, J. Infect. Dis., 209, 1485, 10.1093/infdis/jit660 · DOI
- Pasqua, M., Grossi, M., Zennaro, A., Fanelli, G., Micheli, G., Barras, F., Colonna, B., and Prosseda, G. (2019). The varied role of efflux pumps of the MFS family in the interplay of bacteria with animal and plant cells. Microorganisms, 7. · DOI
- Kumar, 2021, Structural basis of inhibition of a transporter from Staphylococcus aureus, NorC, through a single-domain camelid antibody, Commun. Biol., 4, 1, 10.1038/s42003-021-02357-x · DOI
- Guay, 1993, Expression of the tetK gene from Staphylococcus aureus in Escherichia coli: Comparison of substrate specificities of TetA (B), TetA (C), and TetK efflux proteins, Antimicrob. Agents Chemother., 37, 191, 10.1128/AAC.37.2.191 · DOI
- Guay, 1993, The tet (K) gene of plasmid pT181 of Staphylococcus aureus encodes an efflux protein that contains 14 transmembrane helices, Plasmid, 30, 163, 10.1006/plas.1993.1045 · DOI · Paper page
- Ginn, 1997, Membrane topology of the metal-tetracycline/H+ antiporter TetA (K) from Staphylococcus aureus, J. Bacteriol., 179, 3786, 10.1128/jb.179.11.3786-3789.1997 · doi:10.1128/jb.179.11.3786-3789.1997
- Jin, 2002, Tet (L) and tet (K) tetracycline-divalent metal/H+ antiporters: Characterization of multiple catalytic modes and a mutagenesis approach to differences in their efflux substrate and coupling ion preferences, J. Bacteriol., 184, 4722, 10.1128/JB.184.17.4722-4732.2002 · doi:10.1128/jb.184.17.4722-4732.2002
- Wang, 2000, Two types of Bacillus subtilis tetA (L) deletion strains reveal the physiological importance of TetA (L) in K+ acquisition as well as in Na+, alkali, and tetracycline resistance, J. Bacteriol., 182, 2088, 10.1128/JB.182.8.2088-2095.2000 · DOI
- Krulwich, 2001, Functions of tetracycline efflux proteins that do not involve tetracycline, J. Mol. Microbiol. Biotechnol., 3, 237
- Wang, 2019, Tet38 of Staphylococcus aureus binds to host cell receptor complex CD36-Toll-like receptor 2 and protects from teichoic acid synthesis inhibitors tunicamycin and Congo red, Infect. Immun., 87, e00194-19, 10.1128/IAI.00194-19 · doi:10.1128/iai.00194-19
- Fu, 2016, Prevalence of fosfomycin resistance and mutations in murA, glpT, and uhpT in methicillin-resistant Staphylococcus aureus strains isolated from blood and cerebrospinal fluid samples, Front. Microbiol., 6, 1544, 10.3389/fmicb.2015.01544 · doi:10.3389/fmicb.2015.01544
- Bolduc, 2015, Role of the Tet38 efflux pump in Staphylococcus aureus internalization and survival in epithelial cells, Infect. Immun., 83, 4362, 10.1128/IAI.00723-15 · DOI
- Wang, 2021, Staphylococcus aureus Tet38 efflux pump structural modeling and roles of essential residues in drugs efflux and host cell internalization, Infect. Immun., 89, e00811-20, 10.1128/IAI.00811-20 · doi:10.1128/iai.00811-20
200 of 296 shown
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Silva, K. P. T., Sundar, G., & Khare, A. (2023) · Nature Communications · doi:10.1038/s41467-023-38507-4 · Cited by 44
Metadata
- Authors
- Dashtbani-Roozbehani, A., & Brown, M. H.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2021-12-07
- Volume
- 10
- Issue
- 12
- Pages
- 1502
- ISSN
- 2079-6382
- Cited by
- 115
- References
- 9
- Language
- en
- Funders
- Flinders University (-)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. https://app.cochat.ai/papers/10.3390/antibiotics10121502
- The paper
- Dashtbani-Roozbehani, A., & Brown, M. H. (2021). Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. Antibiotics. https://doi.org/10.3390/antibiotics10121502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.